nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—autistic disorder	0.975	1	CbGaD
Lornoxicam—Tenoxicam—PTGS2—autistic disorder	0.00278	0.429	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—autistic disorder	0.00198	0.306	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—autistic disorder	0.00172	0.265	CrCbGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.000133	0.00723	CbGpPWpGaD
Lornoxicam—PTGS2—Arachidonic acid metabolism—GPX1—autistic disorder	0.000133	0.00723	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—MAOB—autistic disorder	0.000126	0.00687	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—autistic disorder	0.000126	0.00686	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.000125	0.0068	CbGpPWpGaD
Lornoxicam—PTGS2—S1P1 pathway—MAPK1—autistic disorder	0.00012	0.00654	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CAT—autistic disorder	0.000118	0.00641	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—IL6—autistic disorder	0.000117	0.00633	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—autistic disorder	0.000112	0.0061	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTM5—autistic disorder	0.000108	0.00585	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—GPX1—autistic disorder	0.000107	0.00579	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTM5—autistic disorder	0.000106	0.00577	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—autistic disorder	9.86e-05	0.00536	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—autistic disorder	9.84e-05	0.00535	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	9.75e-05	0.0053	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CAT—autistic disorder	9.36e-05	0.00509	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	9.35e-05	0.00508	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—IL6—autistic disorder	9.25e-05	0.00503	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	9.23e-05	0.00501	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PLA2G4A—autistic disorder	9.2e-05	0.005	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—GSTM1—autistic disorder	9.17e-05	0.00498	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—GPX1—autistic disorder	8.81e-05	0.00479	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—autistic disorder	8.66e-05	0.00471	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—GPX1—autistic disorder	8.46e-05	0.0046	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—autistic disorder	8.17e-05	0.00444	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—GJA1—autistic disorder	8.06e-05	0.00438	CbGpPWpGaD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—autistic disorder	7.88e-05	0.00428	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—autistic disorder	7.81e-05	0.00424	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	7.74e-05	0.00421	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP19A1—autistic disorder	7.66e-05	0.00416	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—autistic disorder	7.65e-05	0.00416	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	7.58e-05	0.00412	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—BDNF—autistic disorder	7.32e-05	0.00398	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—autistic disorder	7.26e-05	0.00394	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SERPINE1—autistic disorder	7.19e-05	0.00391	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—COMT—autistic disorder	7.12e-05	0.00387	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTP1—autistic disorder	7.09e-05	0.00385	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—MAOA—autistic disorder	7.07e-05	0.00384	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	7e-05	0.0038	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL4—autistic disorder	6.8e-05	0.00369	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—MAOB—autistic disorder	6.64e-05	0.00361	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IFNG—autistic disorder	6.54e-05	0.00356	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTM1—autistic disorder	6.51e-05	0.00354	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—autistic disorder	6.27e-05	0.00341	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	6.16e-05	0.00335	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ACADSB—autistic disorder	6.09e-05	0.00331	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—INPP1—autistic disorder	6.09e-05	0.00331	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—autistic disorder	5.93e-05	0.00323	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—LEP—autistic disorder	5.75e-05	0.00313	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SERPINE1—autistic disorder	5.7e-05	0.0031	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	5.62e-05	0.00305	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—BCL2—autistic disorder	5.44e-05	0.00296	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AR—autistic disorder	5.44e-05	0.00296	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BTD—autistic disorder	5.43e-05	0.00295	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—NOS2—autistic disorder	5.36e-05	0.00291	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IFNG—autistic disorder	5.2e-05	0.00282	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—autistic disorder	5.19e-05	0.00282	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—RORA—autistic disorder	5.18e-05	0.00282	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BTD—autistic disorder	5.15e-05	0.0028	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	5.12e-05	0.00279	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—autistic disorder	4.98e-05	0.00271	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	4.89e-05	0.00266	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—INPP1—autistic disorder	4.84e-05	0.00263	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACADSB—autistic disorder	4.84e-05	0.00263	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—HRAS—autistic disorder	4.76e-05	0.00259	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	4.75e-05	0.00258	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TDO2—autistic disorder	4.62e-05	0.00251	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—POMC—autistic disorder	4.6e-05	0.0025	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—autistic disorder	4.55e-05	0.00248	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—DHCR7—autistic disorder	4.34e-05	0.00236	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BTD—autistic disorder	4.31e-05	0.00234	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC6A8—autistic disorder	4.11e-05	0.00224	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—EXT1—autistic disorder	4.11e-05	0.00224	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—RORA—autistic disorder	4.11e-05	0.00224	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IFNG—autistic disorder	4.11e-05	0.00223	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP19A1—autistic disorder	4.03e-05	0.00219	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP19A1—autistic disorder	3.97e-05	0.00216	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—DAO—autistic disorder	3.93e-05	0.00213	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EXT1—autistic disorder	3.9e-05	0.00212	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—UPB1—autistic disorder	3.76e-05	0.00205	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—COMT—autistic disorder	3.74e-05	0.00203	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTP1—autistic disorder	3.73e-05	0.00202	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—MAOA—autistic disorder	3.72e-05	0.00202	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—COMT—autistic disorder	3.69e-05	0.00201	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTP1—autistic disorder	3.67e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TDO2—autistic disorder	3.67e-05	0.00199	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL2—autistic disorder	3.65e-05	0.00198	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	3.53e-05	0.00192	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM5—autistic disorder	3.5e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ASMT—autistic disorder	3.5e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	3.49e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—DHCR7—autistic disorder	3.45e-05	0.00187	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTM1—autistic disorder	3.42e-05	0.00186	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL6—autistic disorder	3.42e-05	0.00186	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	3.38e-05	0.00184	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC25A12—autistic disorder	3.29e-05	0.00179	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—EXT1—autistic disorder	3.27e-05	0.00178	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC6A8—autistic disorder	3.27e-05	0.00178	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	3.24e-05	0.00176	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	3.23e-05	0.00176	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—INPP1—autistic disorder	3.2e-05	0.00174	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACADSB—autistic disorder	3.2e-05	0.00174	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC19A1—autistic disorder	3.2e-05	0.00174	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC25A12—autistic disorder	3.12e-05	0.00169	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—DAO—autistic disorder	3.12e-05	0.00169	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC19A1—autistic disorder	3.03e-05	0.00165	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—UPB1—autistic disorder	2.99e-05	0.00162	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—HRAS—autistic disorder	2.94e-05	0.0016	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.94e-05	0.0016	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BTD—autistic disorder	2.85e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADSL—autistic disorder	2.85e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	2.82e-05	0.00153	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—XDH—autistic disorder	2.8e-05	0.00152	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MAPK1—autistic disorder	2.79e-05	0.00152	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM5—autistic disorder	2.78e-05	0.00151	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ASMT—autistic disorder	2.78e-05	0.00151	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—STX1A—autistic disorder	2.75e-05	0.00149	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NPAS2—autistic disorder	2.75e-05	0.00149	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	2.72e-05	0.00148	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL6—autistic disorder	2.71e-05	0.00148	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TCN2—autistic disorder	2.65e-05	0.00144	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC25A12—autistic disorder	2.61e-05	0.00142	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STX1A—autistic disorder	2.6e-05	0.00141	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC19A1—autistic disorder	2.54e-05	0.00138	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADA—autistic disorder	2.53e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TCN2—autistic disorder	2.51e-05	0.00137	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.5e-05	0.00136	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—WNT2—autistic disorder	2.43e-05	0.00132	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TDO2—autistic disorder	2.43e-05	0.00132	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—POMC—autistic disorder	2.42e-05	0.00132	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.39e-05	0.0013	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	2.34e-05	0.00127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.33e-05	0.00127	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—RORA—autistic disorder	2.31e-05	0.00125	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—DHCR7—autistic disorder	2.28e-05	0.00124	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADSL—autistic disorder	2.26e-05	0.00123	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—XDH—autistic disorder	2.22e-05	0.00121	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—STX1A—autistic disorder	2.18e-05	0.00118	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NPAS2—autistic disorder	2.18e-05	0.00118	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—EXT1—autistic disorder	2.16e-05	0.00118	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC6A8—autistic disorder	2.16e-05	0.00118	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MAOB—autistic disorder	2.16e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL6—autistic disorder	2.15e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TCN2—autistic disorder	2.1e-05	0.00114	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—DAO—autistic disorder	2.06e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.06e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TPH2—autistic disorder	2.01e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPL10—autistic disorder	2.01e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADA—autistic disorder	2.01e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.98e-05	0.00108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UPB1—autistic disorder	1.98e-05	0.00108	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—DPYD—autistic disorder	1.98e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.9e-05	0.00103	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	1.9e-05	0.00103	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.86e-05	0.00101	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ASMT—autistic disorder	1.84e-05	0.001	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM5—autistic disorder	1.84e-05	0.001	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CACNA1C—autistic disorder	1.84e-05	0.000999	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—RORA—autistic disorder	1.83e-05	0.000995	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.77e-05	0.000961	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC25A12—autistic disorder	1.73e-05	0.00094	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MAOB—autistic disorder	1.72e-05	0.000933	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC19A1—autistic disorder	1.68e-05	0.000914	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—DHFR—autistic disorder	1.67e-05	0.000909	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.63e-05	0.000888	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TPH2—autistic disorder	1.6e-05	0.000867	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—DHFR—autistic disorder	1.59e-05	0.000862	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—DPYD—autistic disorder	1.57e-05	0.000853	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	1.55e-05	0.00084	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADSL—autistic disorder	1.5e-05	0.000815	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.47e-05	0.000801	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—XDH—autistic disorder	1.47e-05	0.000799	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CACNA1C—autistic disorder	1.46e-05	0.000793	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—STX1A—autistic disorder	1.44e-05	0.000785	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NPAS2—autistic disorder	1.44e-05	0.000785	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALCA—autistic disorder	1.43e-05	0.000775	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.41e-05	0.000766	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.4e-05	0.000763	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TCN2—autistic disorder	1.39e-05	0.000758	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADA—autistic disorder	1.33e-05	0.000723	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—DHFR—autistic disorder	1.33e-05	0.000722	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.31e-05	0.000714	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP19A1—autistic disorder	1.31e-05	0.000712	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRL—autistic disorder	1.26e-05	0.000685	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.26e-05	0.000684	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.23e-05	0.000668	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—COMT—autistic disorder	1.22e-05	0.000662	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—RORA—autistic disorder	1.21e-05	0.000659	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—autistic disorder	1.21e-05	0.000659	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MAOA—autistic disorder	1.21e-05	0.000657	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAT—autistic disorder	1.18e-05	0.000641	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MAOB—autistic disorder	1.14e-05	0.000618	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PLA2G4A—autistic disorder	1.11e-05	0.000605	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—autistic disorder	1.11e-05	0.000605	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.08e-05	0.000588	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPX1—autistic disorder	1.07e-05	0.00058	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TPH2—autistic disorder	1.06e-05	0.000574	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP19A1—autistic disorder	1.04e-05	0.000565	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—DPYD—autistic disorder	1.04e-05	0.000565	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—autistic disorder	9.84e-06	0.000535	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	9.76e-06	0.000531	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	9.76e-06	0.00053	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—COMT—autistic disorder	9.67e-06	0.000525	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CACNA1C—autistic disorder	9.66e-06	0.000525	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—autistic disorder	9.62e-06	0.000523	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MAOA—autistic disorder	9.6e-06	0.000522	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAT—autistic disorder	9.36e-06	0.000509	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—autistic disorder	9.33e-06	0.000507	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HLA-A—autistic disorder	9.3e-06	0.000506	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	9.29e-06	0.000505	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—APOE—autistic disorder	9.16e-06	0.000498	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TSC2—autistic disorder	8.87e-06	0.000482	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—autistic disorder	8.84e-06	0.000481	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PLA2G4A—autistic disorder	8.84e-06	0.000481	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—DHFR—autistic disorder	8.79e-06	0.000478	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APOE—autistic disorder	8.68e-06	0.000472	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPX1—autistic disorder	8.47e-06	0.00046	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CG—autistic disorder	8.27e-06	0.000449	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS2—autistic disorder	8.09e-06	0.00044	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—POMC—autistic disorder	7.87e-06	0.000428	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APC—autistic disorder	7.84e-06	0.000426	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—autistic disorder	7.81e-06	0.000425	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGF—autistic disorder	7.75e-06	0.000421	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.41e-06	0.000403	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—APOE—autistic disorder	7.27e-06	0.000395	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP19A1—autistic disorder	6.88e-06	0.000374	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SERPINE1—autistic disorder	6.81e-06	0.00037	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CG—autistic disorder	6.56e-06	0.000357	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.46e-06	0.000351	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—COMT—autistic disorder	6.4e-06	0.000348	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—autistic disorder	6.37e-06	0.000346	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MAOA—autistic disorder	6.36e-06	0.000345	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—autistic disorder	6.28e-06	0.000341	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—POMC—autistic disorder	6.25e-06	0.00034	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAT—autistic disorder	6.2e-06	0.000337	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PLA2G4A—autistic disorder	5.85e-06	0.000318	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM1—autistic disorder	5.85e-06	0.000318	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX1—autistic disorder	5.61e-06	0.000305	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—autistic disorder	5.47e-06	0.000298	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—autistic disorder	5.19e-06	0.000282	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—autistic disorder	5.17e-06	0.000281	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—APOE—autistic disorder	4.82e-06	0.000262	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CG—autistic disorder	4.35e-06	0.000236	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—autistic disorder	4.35e-06	0.000236	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAPK1—autistic disorder	4.22e-06	0.000229	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—POMC—autistic disorder	4.14e-06	0.000225	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HRAS—autistic disorder	3.39e-06	0.000184	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—autistic disorder	3.3e-06	0.000179	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—autistic disorder	3.24e-06	0.000176	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—autistic disorder	2.88e-06	0.000156	CbGpPWpGaD
